Most of the ALLs have –
First, I need to figure out the correct answer. The question is asking what most ALL cases have. Common features of ALL include specific chromosomal abnormalities or markers. The most common one is the Philadelphia chromosome, which is a translocation between chromosomes 9 and 22 (t(9;22)), leading to the BCR-ABL1 fusion gene. This is present in about 25% of ALL cases. But wait, is there a more common marker? Let me recall. Another common one is the TEL-AML1 fusion (ETV6-RUNX1) from t(12;21), which is actually the most common in pediatric ALL, occurring in about 25% of cases. So maybe the correct answer is TEL-AML1.
Wait, the options aren't given, but the user might have intended the correct answer to be TEL-AML1. Let me confirm. TEL-AML1 is the most frequent translocation in ALL, especially in children. The Philadelphia chromosome is less common, around 25%. So the core concept here is the common genetic abnormalities in ALL.
Now, structuring the explanation. The core concept would mention the genetic abnormalities in ALL. The correct answer explanation would detail the TEL-AML1 translocation, its mechanism, and its prevalence. The incorrect options would be other translocations like BCR-ABL1, E2A-PBX1, or hyperdiploidy. Each of these needs a brief explanation of why they are less common.
Clinical pearl should highlight TEL-AML1 as the most common in pediatric ALL and its implication in prognosis. The correct answer line would be the option corresponding to TEL-AML1.
I need to make sure all sections are covered and the explanations are concise. Let me check the character count to stay within 2500. Also, use bold for key terms and structure each section properly without markdown headings.
**Core Concept**
Acute lymphoblastic leukemia (ALL) is characterized by clonal proliferation of lymphoblasts, often with specific chromosomal translocations. The most common genetic abnormalities in ALL include **TEL-AML1 (ETV6-RUNX1)**, **BCR-ABL1**, and **E2A-PBX1**, which influence prognosis and treatment strategies.
**Why the Correct Answer is Right**
TEL-AML1 (t(12;21)(p13;q22)) is the most frequent translocation in pediatric ALL (~25% of cases). It fuses the **ETV6** gene (chromosome 12) with **RUNX1** (chromosome 21), creating a fusion protein that disrupts normal hematopoiesis. This translocation is associated with a favorable prognosis due to its correlation with younger age, lower white blood cell counts, and better response to chemotherapy.
**Why Each Wrong Option is Incorrect**
**Option A:** BCR-ABL1 (Philadelphia chromosome) occurs in ~25% of adult ALL cases but is rare in children. It drives constitutive tyrosine kinase activity, leading